← Leaderboards
John P Forman
Brigham And Women'S Hospital
$11,830,902
Attributed
$13,474,574
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2006–20$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$13,474,574 · 6
By mechanism
R01$12,692,922 · 3
K08$673,650 · 1
F32$108,002 · 2
Top collaborators
- Howard D Sesso7 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Frank A Scheer$22,110,197
- Ravi Thadhani$43,973,148
- Gail Kurr Adler$16,472,973
- David John Hunter$28,422,931
- Daniel Hal Solomon$26,002,677
Others in their field
Top investigators on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Paula Darby Lipman · Westat, Inc.$52,914,492
- Walter N Kernan · Yale University$42,197,025
- Rohit Varma · University Of Southern California$35,266,606
- Susan S Redline · Brigham And Women'S Hospital$35,248,244
- Marlene Rabinovitch · Stanford University$34,807,202
Research focus
HypertensionPlasmaRenin-Angiotensin SystemReninBlood PressureBlood VesselsHourCardiovascular DiseasesFutureVitamin DAngiotensin IiPreventSupplementationExcretory FunctionEnrollmentRandomizedDesign25-Hydroxyvitamin DIncidencePlacebosDouble-Blind MethodMediator Of Activation ProteinAffectInsulin Sensitivity
Grant awards (28)
THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES$668,804
R01 · FY2020 · HL · contact PI
THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES$668,804
R01 · FY2019 · HL · contact PI
THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES$668,655
R01 · FY2018 · HL · contact PI
THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES$675,142
R01 · FY2017 · HL · contact PI
THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES$669,302
R01 · FY2016 · HL · contact PI
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension$643,706
R01 · FY2016 · HL
MODifiable Effectors of Renin System Activation: Treatment Evaluation$697,921
R01 · FY2015 · HL · contact PI
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension$626,195
R01 · FY2015 · HL
MODifiable Effectors of Renin System Activation: Treatment Evaluation$692,844
R01 · FY2014 · HL · contact PI
The Role of Circadian Periodicity in Human Cardiovascular Disease and Diabetes$665,377
R01 · FY2014 · HL · contact PI
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension$113,362
R01 · FY2014 · HL
MODifiable Effectors of Renin System Activation: Treatment Evaluation$668,224
R01 · FY2013 · HL · contact PI
The Role of Circadian Periodicity in Human Cardiovascular Disease and Diabetes$646,054
R01 · FY2013 · HL · contact PI
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension$601,668
R01 · FY2013 · HL
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension$26,712
R01 · FY2013 · HL
MODifiable Effectors of Renin System Activation: Treatment Evaluation$700,477
R01 · FY2012 · HL · contact PI
The Role of Circadian Periodicity in Human Cardiovascular Disease and Diabetes$673,844
R01 · FY2012 · HL · contact PI
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension$639,263
R01 · FY2012 · HL
MODifiable Effectors of Renin System Activation: Treatment Evaluation$768,250
R01 · FY2011 · HL · contact PI
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension$636,438
R01 · FY2011 · HL
The Role of Circadian Periodicity in Human Cardiovascular Disease and Diabetes$541,880
R01 · FY2011 · HL · contact PI
Novel Risk Factors For Hypertension$134,730
K08 · FY2010 · HL · contact PI
Novel Risk Factors For Hypertension$134,730
K08 · FY2009 · HL · contact PI
Novel Risk Factors For Hypertension$134,730
K08 · FY2008 · HL · contact PI
Novel Risk Factors For Hypertension$134,730
K08 · FY2007 · HL · contact PI
Novel Risk Factors For Hypertension$134,730
K08 · FY2006 · HL · contact PI
Folic Acid Intake and Risk of Hypertension$59,854
F32 · FY2004 · HL
ICOS-B7h Costimulatory Pathway in Allograft Dysfunction$48,148
F32 · FY2002 · AI